Cargando…
Proteomics identifies differentially expressed proteins in glioblastoma U87 cells treated with hederagenin
OBJECTIVE: We investigated differentially expressed proteins (DEPs) in human glioblastoma U87 cells after treatment with hederagenin as a therapeutic screening mechanism and provided a theoretical basis for hederagenin in treating glioblastoma. METHODS: The Cell Counting Kit 8 assay was used to anal...
Autores principales: | Zhang, Yesen, Han, Yi, Shang, Yuchun, Wang, Xiangyu, Sun, Jiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148390/ https://www.ncbi.nlm.nih.gov/pubmed/37120556 http://dx.doi.org/10.1186/s12953-023-00208-7 |
Ejemplares similares
-
Exosome Proteome of U-87MG Glioblastoma Cells
por: Chun, Sohyun, et al.
Publicado: (2016) -
Screening seven hub genes associated with prognosis and immune infiltration in glioblastoma
por: Zhang, Yesen, et al.
Publicado: (2022) -
Experimental Study of Antiatherosclerosis Effects with Hederagenin in Rats
por: Lu, Su-Hong, et al.
Publicado: (2015) -
Investigation of platinum nanoparticle properties against U87 glioblastoma multiforme
por: Kutwin, Marta, et al.
Publicado: (2016) -
Hederagenin Supplementation Alleviates the Pro-Inflammatory and Apoptotic Response to Alcohol in Rats
por: Kim, Gyeong-Ji, et al.
Publicado: (2017)